<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182019000400685</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación pronóstica del síndrome coronario agudo en pacientes con síndrome metabólico]]></article-title>
<article-title xml:lang="en"><![CDATA[Prognostic evaluation of acute coronary syndrome in patients with metabolic syndrome]]></article-title>
<article-title xml:lang="pt"><![CDATA[Avaliação prognóstica da síndrome coronariana aguda em pacientes com síndrome metabólica]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Domínguez]]></surname>
<given-names><![CDATA[Julio Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Boza Torres]]></surname>
<given-names><![CDATA[Pedro Emilio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Del Castillo Sánchez]]></surname>
<given-names><![CDATA[Ibelsys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cervantes Castro]]></surname>
<given-names><![CDATA[Luis Felipe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Sidenko]]></surname>
<given-names><![CDATA[Alexander]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Oliva]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Hospital General Provincial Universitario Carlos Manuel de Céspedes ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<volume>23</volume>
<numero>4</numero>
<fpage>685</fpage>
<lpage>698</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182019000400685&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182019000400685&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182019000400685&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el síndrome metabólico incrementa el riesgo para enfermedad cardiovascular y duplica la mortalidad.  Objetivo:  identificar los factores pronósticos de muerte por síndrome coronario agudo en pacientes con síndrome metabólico.  Método:  se realizó estudio observacional analítico de cohorte en 186 pacientes con síndrome coronario agudo admitidos entre 01 febrero de 2015 y 20 de octubre de 2018. Se incluyeron variables clínicas y epidemiológicas; se evaluó la fuerza de asociación entre las variables cualitativas y el riesgo de desarrollar muerte por síndrome coronario agudo en presencia de síndrome metabólico con el Odds Ratio con intervalo de confianza al 95%. Se realizó análisis multivariado utilizando el modelo de regresión logística de Cox.  Resultados:  la prevalencia del síndrome metabólico fue 45,7 %, con edad media de 60,6 años; sexo femenino y grupo de edades mayor de 61 años duplicaron el riesgo de forma no significativa. Hipertrofia ventricular izquierda, insuficiencia cardiaca y fibrilación auricular incrementaron el riesgo de aparición de síndrome coronario agudo estadísticamente significativa en presencia del síndrome metabólico, p, 000. Disfunción ventricular izquierda moderada a severa [OR 5.7 IC 95 % (1,115-5,961) p, 000], clase de Killip-Kimball &#8805;II [OR 7,9 IC 95 % (3,10-20,15) p, 000] e infarto sin elevación del ST [OR 2,970 IC 95 % (1,174-7,518) p, 000], se relacionaron significativamente con la muerte.  Conclusiones:  el síndrome metabólico incrementa el riesgo de sufrir síndrome coronario agudo y muerte pero no está relacionado significativamente con la supervivencia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  metabolic syndrome increases the risk for cardiovascular disease and doubles mortality.  Objective:  to identify the prognostic factors of death due to acute coronary syndrome in patients with metabolic syndrome.  Method:  a cohort analytical observational study was conducted in 186 patients with acute coronary syndrome admitted between 01 February 2015 and 20 October 2018. Clinical and epidemiological variables were included; the strength of association between the qualitative variables and the risk of developing death due to acute coronary syndrome in the presence of metabolic syndrome with Odds Ratio with 95% confidence interval was evaluated. Multivariate analysis was performed using the Cox logistic regression model.  Results:  the prevalence of the metabolic syndrome was 45.7%, with a mean age of 60.6 years; Female sex and age group over 61 years doubled the risk in a non-significant way. Left ventricular hypertrophy, heart failure and atrial fibrillation increased the risk of the appearance of a statistically significant acute coronary syndrome in the presence of the metabolic syndrome, p, 000. Moderate to severe left ventricular dysfunction [OR 5.7 95% CI (1,115-5,961) p, 000], Killip-Kimball class &#8805;II [OR 7.9 IC 95% (3, 10-20, 15) p, 000] and infarction without ST elevation [OR 2.970 95% CI (1.174-7.518) p, 000], were significantly related to death.  Conclusions:  metabolic syndrome increases the risk of suffering acute coronary syndrome and death but it is not significantly related to survival.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  a síndrome metabólica aumenta o risco de doença cardiovascular e duplica a mortalidade.  Objetivo:  identificar os fatores prognósticos do óbito por síndrome coronariana aguda em pacientes com síndrome metabólica.  Método:  estudo de coorte observacional analítico foi realizado em 186 pacientes com síndrome coronariana aguda admitidos entre 01 de fevereiro de 2015 e 20 de Outubro de 2018. Foram incluídos variáveis &#8203;&#8203;clínicas e epidemiológicas; a força de associação entre variáveis &#8203;&#8203;qualitativas e o risco de morte por síndrome coronária aguda, na presença de síndrome metabólica com probabilidades confiança Rácio intervalo de 95% foi avaliada. A análise multivariada foi realizada usando o modelo de regressão logística de Cox.  Resultados:  a prevalência da síndrome metabólica foi de 45,7%, com idade média de 60,6 anos; Sexo feminino e faixa etária acima de 61 anos dobraram o risco de forma não significativa. hipertrofia do ventrículo esquerdo, falha cardíaca e fibrilação atrial aumentou o risco de síndroma coronária aguda estatisticamente significativa na presença de síndroma metabólico, p, 000. Disfunção Ventricular Esquerda moderada a grave [OU 5,7 (IC 95% 1,115-5,961) p.000], Killip-Kimball &#8805;II [OR 7,9, IC de 95% (3,10-20,15) p.000] e enfarte sem elevação do segmento ST [OR 95% CI 2,970 (1,174-7,518) p.000], estavam significativamente relacionados com a morte.  Conclusões:  A síndrome metabólica aumenta o risco de síndrome coronariana aguda e morte, mas não significativamente associada com a sobrevivência.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Síndrome Coronario Agudo]]></kwd>
<kwd lng="es"><![CDATA[Síndrome Metabólico]]></kwd>
<kwd lng="en"><![CDATA[Acute Coronary Syndrom]]></kwd>
<kwd lng="en"><![CDATA[Metabolic Syndrome]]></kwd>
<kwd lng="pt"><![CDATA[Síndrome Coronariana Aguda]]></kwd>
<kwd lng="pt"><![CDATA[Síndrome metabólico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fonte Medina]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabría Negrín]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Bencomo Fonte]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Fonte Medina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Negreria]]></surname>
<given-names><![CDATA[IL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados y prevalencia de síndrome metabólico en la tercera edad]]></article-title>
<source><![CDATA[Rev Cienc Méd de Pinar del Río]]></source>
<year>2014</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>963-73</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdés Ramos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bencosme Rodríguez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico y enfermedad cardiovascular en personas con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev Cub Endocrinol]]></source>
<year>2013</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>125-35</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Travieso]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome Metabólico y Riesgo Cardiovascular Rev]]></article-title>
<source><![CDATA[CENIC Ciencias Biológicas]]></source>
<year>2016</year>
<volume>47</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>106-19</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bojorges]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo de síndrome metabólico en estudiantes de la universidad Pablo Guardado Chávez, año 2013]]></article-title>
<source><![CDATA[Rev Cubana Investig Biom]]></source>
<year>2013</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>379-88</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bassi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Karagodin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vassallo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Priyanath]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Massaro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Stone]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lifestyle modification for metabolic syndrome: a systematic review]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2014</year>
<volume>127</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1242.e1-10</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calton]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Pannu]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Certain dietary patterns are beneficial for the metabolic syndrome reviewing the evidence]]></article-title>
<source><![CDATA[Nutr Res]]></source>
<year>2014</year>
<volume>34</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>559-68</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agramonte Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Barnés Domínguez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto Correa]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia del síndrome metabólico en pacientes diabéticos tipo 2]]></article-title>
<source><![CDATA[Rev Cubana Med]]></source>
<year>2009</year>
<volume>48</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bell Castillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[George Carrión]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[García Céspedes]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado Bell]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identificación del síndrome metabólico en pacientes con diabetes mellitus e hipertensión arterial]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2017</year>
<volume>21</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3038-45</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olijhoek]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Van der Graaf]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Banga]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Algra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rabelink]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Visseren]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2004</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>342-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Madrid-Miller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alcaraz-Ruiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Borrayo-Sánchez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida-Gutiérrez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas-Guzmán]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Jáuregui-Aguilar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome Metabólico, impacto clínico y angiografíco en pacientes con Síndrome Coronario Agudo]]></article-title>
<source><![CDATA[Cir Cir]]></source>
<year>2010</year>
<volume>78</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115-23</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>Consenso Latinoamericano de la Asociación Latinoamericana de Diabetes</collab>
<article-title xml:lang=""><![CDATA[Epidemiología, diagnóstico, control, prevención y tratamiento del síndrome metabólico en adultos]]></article-title>
<source><![CDATA[Rev Asoc Latinoam Diab]]></source>
<year>2010</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-44</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tzorin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chopox]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia de Síndrome Metabólico en personal de mantenimiento que labora dentro del campus central de la Universidad de San Carlos de Guatemala, en el año 2014]]></article-title>
<source><![CDATA[Rev Cientif de la Facultad de Ciencias Químicas y Farmacia]]></source>
<year>2015</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-17</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lizarzaburu Robles]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico: concepto y aplicación práctica]]></article-title>
<source><![CDATA[An Fac med]]></source>
<year>2013</year>
<volume>74</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>315-20</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Contreras]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mata]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico y diabetes mellitus tipo 2 en población adulta Los salías, Edo. Miranda-Venezuela]]></article-title>
<source><![CDATA[Síndrome Cardiometabólico]]></source>
<year>2015</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-23</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Won]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Jeon]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes]]></article-title>
<source><![CDATA[Cardiovasc Diab]]></source>
<year>2013</year>
<volume>12</volume>
<page-range>41</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jover]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Corbella]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Millán]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pintó]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Mangas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2011</year>
<volume>64</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>579-86</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piombo]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Gagliardi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Crotto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ulmete]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Guetta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia, características y valor pronóstico del síndrome metabólico en los síndromes coronarios agudos]]></article-title>
<source><![CDATA[Rev Arg Cardiol]]></source>
<year>2005</year>
<volume>73</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>424-8</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gregory]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Christopher]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Mohsen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global Regional and National Burden of Cardiovascular Diseases for 10 Causes 1990 to 2015]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2017</year>
<volume>70</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-25</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
